稳健医疗
(300888)
| 流通市值：60.63亿 | | | 总市值：196.43亿 |
| 流通股本：1.82亿 | | | 总股本：5.88亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 6,010,442,517 | 4,266,838,038.66 | 2,352,114,690.56 | 11,351,331,545.08 |
| 营业收入 | 6,010,442,517 | 4,266,838,038.66 | 2,352,114,690.56 | 11,351,331,545.08 |
| 二、营业总成本 | 5,112,656,537.02 | 3,500,655,804.36 | 1,885,291,798.07 | 9,119,688,180.06 |
| 营业成本 | 2,994,955,389.26 | 2,071,428,206.72 | 1,153,342,607.77 | 5,972,800,817.29 |
| 税金及附加 | 50,010,713.43 | 37,346,208.61 | 19,258,686.12 | 98,087,240.32 |
| 销售费用 | 1,445,506,563.06 | 960,442,911.44 | 470,319,611.47 | 2,050,176,407.46 |
| 管理费用 | 430,384,084.74 | 289,596,702.14 | 148,745,353.84 | 633,614,634.95 |
| 研发费用 | 268,896,680.42 | 194,636,202.14 | 111,178,989.49 | 487,583,652.11 |
| 财务费用 | -77,096,893.89 | -52,794,426.69 | -17,553,450.62 | -122,574,572.07 |
| 其中:利息费用 | 48,395,021.97 | 32,891,514.25 | 15,569,859.54 | 50,057,668.71 |
| 其中:利息收入 | 108,787,535.6 | 69,863,134.66 | 33,167,722.84 | 123,909,561.75 |
| 加:公允价值变动收益 | 59,575,027.27 | 59,639,836.03 | 46,133,616.18 | 32,148,876.44 |
| 加:投资收益 | 75,841,901.89 | 39,412,441.13 | 12,542,211.37 | 51,470,767.16 |
| 资产处置收益 | 1,601,841,961.82 | 5,324,751.1 | 0 | 3,726,204.37 |
| 资产减值损失(新) | -147,432,281.86 | -100,794,883.37 | -94,990,599.76 | -362,869,340.23 |
| 信用减值损失(新) | 201,628.94 | 2,831,973.61 | 2,319,791.09 | -63,943,322.52 |
| 其他收益 | 69,648,999.28 | 46,680,694.51 | 19,878,777.62 | 84,373,262.34 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 2,557,463,217.32 | 819,277,047.31 | 452,706,688.99 | 1,976,549,812.58 |
| 加:营业外收入 | 8,777,607.21 | 6,702,598.77 | 1,835,700.21 | 10,569,559.38 |
| 减:营业外支出 | 10,499,012.19 | 4,906,948.03 | 1,378,322.7 | 67,613,275.63 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 2,555,741,812.34 | 821,072,698.05 | 453,164,066.5 | 1,919,506,096.33 |
| 减:所得税费用 | 369,809,886.4 | 114,886,459.15 | 65,223,533.57 | 245,301,544.88 |
| 六、净利润 | 2,185,931,925.94 | 706,186,238.9 | 387,940,532.93 | 1,674,204,551.45 |
| 持续经营净利润 | 2,185,931,925.94 | 706,186,238.9 | 387,940,532.93 | 1,674,204,551.45 |
| 归属于母公司股东的净利润 | 2,147,773,293.68 | 681,617,022.69 | 376,938,135.34 | 1,650,582,427.43 |
| 少数股东损益 | 38,158,632.26 | 24,569,216.21 | 11,002,397.59 | 23,622,124.02 |
| (一)基本每股收益 | 3.65 | 1.16 | 0.89 | 3.9 |
| (二)稀释每股收益 | 3.65 | 1.16 | 0.89 | 3.9 |
| 八、其他综合收益 | 1,918,869.33 | 2,650,491.58 | -725,528.08 | 3,547,462.46 |
| 归属于母公司股东的其他综合收益 | 1,168,773.22 | 1,563,872.28 | -417,226.2 | 2,339,713.58 |
| 九、综合收益总额 | 2,187,850,795.27 | 708,836,730.48 | 387,215,004.85 | 1,677,752,013.91 |
| 归属于母公司股东的综合收益总额 | 2,148,942,066.9 | 683,180,894.97 | 376,520,909.14 | 1,652,922,141.01 |
| 归属于少数股东的综合收益总额 | 38,908,728.37 | 25,655,835.51 | 10,694,095.71 | 24,829,872.9 |
| 公告日期 | 2023-10-24 | 2023-08-16 | 2023-04-25 | 2023-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |